Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | DVL3 |
| Upstream (Parents) |
|---|
| (<<) CSNK1D → DVL3 |
| (<<) DHX9 → DVL3 |
| (<<) ELF2 → DVL3 |
| (<<) GNB2 → DVL3 |
| (<<) GSK3B → DVL3 |
| (<<) IL1B → DVL3 |
| (<<) JUND → DVL3 |
| (<<) KLK8 → DVL3 |
| (<<) MAP2K3 → DVL3 |
| (<<) MEF2A → DVL3 |
| (<<) PRKCD → DVL3 |
| (<<) PRR7 → DVL3 |
| (<<) PYGB → DVL3 |
| (<<) RORA → DVL3 |
| (<<) RXRA → DVL3 |
| (<<) SPDEF → DVL3 |
| (<<) STK4 → DVL3 |
| (<<) TIMP2 → DVL3 |
| (<<) TPSG1 → DVL3 |
| Downstream (Children) |
|---|
| DVL3 → BMP1 (>>) |
| DVL3 → CALML5 (>>) |
| DVL3 → CAMKK2 (>>) |
| DVL3 → ICAM1 (>>) |
| DVL3 → NFIX (>>) |
| DVL3 → RRP1 (>>) |
| DVL3 → WNT6 (>>) |
